End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.88 CNY | +2.93% | +2.54% | +11.13% |
Strengths
- This company will be of major interest to investors in search of a high dividend stock.
Ratings chart - Surperformance
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+11.13% | 2.02B | - | - | |
+5.38% | 71.19B | A | ||
+12.55% | 9.3B | A- | ||
-13.75% | 5.01B | A- | ||
+42.38% | 4.47B | - | ||
+4.51% | 3.96B | B- | ||
+21.10% | 2.44B | B | ||
-19.05% | 2.41B | C- | ||
-28.72% | 2.23B | - | ||
+6.53% | 1.69B | D+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 600420 Stock
- Ratings Shanghai Shyndec Pharmaceutical Co., Ltd.